BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12485499)

  • 1. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
    Ma D; Liu X; Cai Z; Xie Q
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
    Ma DL; Liu XH; Bai CG; Xie Q; Feng F
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of c-kit oncogene in gastrointestinal stromal tumors].
    Liu X; Ma D; Wu L; Bai C; Hu H
    Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):277-9. PubMed ID: 12133359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of c-kit gene mutations in gastrointestinal stromal tumors].
    Hou YY; Sun MH; Tan YS; Wei YK; Lu XY; Zhang TM; Du X; Wang J; Zhu XZ
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):89-92. PubMed ID: 15059325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S; Chen LR; Wang HJ; Chen SZ
    Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
    Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
    Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
    Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
    Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors.
    Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
    Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y
    J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
    Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
    J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological analysis of gastrointestinal stromal tumors.
    Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
    Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times.
    Inoue T; Suzuki T; Nakagawa K; Kurokawa Y; Satomi S; Moriya T; Sasano N; Sasano H
    Pathol Int; 2004 Mar; 54(3):196-200. PubMed ID: 14989743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple gastrointestinal stromal tumors with a germline c-kit mutation.
    Kim HJ; Lim SJ; Park K; Yuh YJ; Jang SJ; Choi J
    Pathol Int; 2005 Oct; 55(10):655-9. PubMed ID: 16185297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.